Chelsea
Pre-Approval PRO BETAInactive Company
No clinical trial activity in 3+ years. This company may have been acquired, shut down, or pivoted away from clinical development. Last trial started: 11/1/2013
Pipeline by Phase
Therapeutic Focus
Clinical Trials (15)
Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH) (Droxi-304)
Started: 1/1/2009
A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa Therapy
Started: 11/1/2013
A Two Part Study (306A/306B) to Assess Droxidopa in Treatment of NOH in Patients With Parkinson's Disease
Started: 6/1/2010
Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)
Started: 1/1/2008
Open-Label Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)
Started: 1/1/2008
A Clinical Study for Patients With Neurogenic Orthostatic Hypotension (NOH) Using Droxidopa
Started: 9/1/2008
Study of Droxidopa Treatment in Adults With Attention Deficit Hyperactivity Disorder With Co-administration of Carbidopa
Started: 10/1/2009
Study To Assess The Clinical Benefit Of Droxidopa And Droxidopa/Carbidopa In Subjects With Fibromyalgia
Started: 1/1/2009
Study To Assess The Clinical Benefit Of Droxidopa In Subjects With Chronic Fatigue Syndrome
Started: 7/1/2010
A Study of CH-4051 in Patients With Rheumatoid Arthritis (RA)
Started: 9/1/2010
A Study to Assess CH1504 in Patients With Active Rheumatoid Arthritis
Started: 4/1/2008
Study to Assess Droxidopa in the Treatment of Freezing Of Gait Symptoms in Patients With Parkinson's Disease
Started: 4/1/2012
Study of the Fed-Fast Pharmocokinetics and Bioequivalance of 300mg Capsules of Droxidopa
Started: 7/1/2010
Electrocardiographic (ECG) Safety Study of Droxidopa at Clinical and Supratherapeutic Dose
Started: 3/1/2011